Showing results (131-140 of 142) with videos related to
Sort By:
Pageof 15
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 30, 2009
Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to ratsHoufu Liu, Junling Yang, Feifei Du, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 14, 2008
Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicineTong Lu, Junling Yang, Xiumei Gao, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 4, 2016
Pharmacokinetics and Disposition of Circulating Iridoids and Organic Acids in Rats Intravenously Receiving ReDuNing InjectionChen Cheng, Feifei Du, Ke Yu, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2018
Pharmacokinetics-Based Identification of Potential Therapeutic Phthalides from XueBiJing, a Chinese Herbal Injection Used in Sepsis ManagementNating Zhang, Chen Cheng, Olajide E Olaleye, et al.Chinese Journal of Natural Medicines|February 11, 2024
Composition analysis of Compound Shenhua Tablet, a seven-herb Chinese medicine for IgA nephropathy: evaluation of analyte-capacity of the assaysHaiyan Zhang, Qiuyue Wang, Jianan Wang, et al.Redox Biology|October 10, 2023
Fullerol rescues the light-induced retinal damage by modulating Müller glia cell fateZhe Cha, Zhiyuan Yin, Luodan A, et al.Biomed Research International|August 21, 2019
Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem CellsChen Dong, Qiao Zhou, Ting Fu, et al.Journal of Nanobiotechnology|December 20, 2024
Circulating plasma derived exosomes from systemic lupus erythematosus aggravate lupus nephritis through miR-122-5p/FOXO3-mediated macrophage activationJuan Ji, Qian He, Yunfei Xia, et al.European Journal of Pharmacology|July 28, 2024
Overexpression of miR-20a-5p in mesenchymal stem cell derived-exosomes from systemic lupus erythematosus patients restored therapeutic effect and Treg immune regulationJuan Ji, Qian Liang, Qian He, et al.Journal of Nanobiotechnology|May 16, 2025
M2-ApoBDs as a therapeutic strategy for systemic lupus erythematosus: targeted macrophage reprogramming and treg differentiationJuan Ji, Shaoying Yang, Yongxin Xu, et al.Pageof 15